Literature DB >> 17156268

Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients.

G Tsivgoulis1, N Triantafyllou, C Papageorgiou, M E Evangelopoulos, E Kararizou, C Sfagos, D Vassilopoulos.   

Abstract

OBJECTIVES: We evaluated cross-sectionally the associations of depression and anxiety with age, sex, duration of illness, educational level, degree of disability and treatment with interferon-beta in outpatients with relapsing-remitting multiple sclerosis (RRMS) during a clinically stable phase of their illness.
MATERIALS AND METHODS: The depression status scored on the Beck Depression Inventory (BDI), the symptoms of anxiety assessed using the State Trait Anxiety Inventory (STAI) and the level of disability measured by the Expanded Disability Status Scale (EDSS) were quantified in 86 consecutive RRMS patients.
RESULTS: Linear regression analyses indicated that EDSS was independently (P < 0.001) associated with BDI and STAI and accounted for 15.7% and 18.5% of the variance in BDI and STAI respectively. The former association retained its statistical significance in multiple regression models adjusting for demographic and clinical characteristics.
CONCLUSIONS: Disability status is an independent but moderate determinant of depression and anxiety in MS patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17156268     DOI: 10.1111/j.1600-0404.2006.00736.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  17 in total

1.  Validation of mood measures for people with multiple sclerosis.

Authors:  Tessa M Watson; Emma Ford; Esme Worthington; Nadina B Lincoln
Journal:  Int J MS Care       Date:  2014

2.  Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.

Authors:  Ana Paula Kallaur; Josiane Lopes; Sayonara Rangel Oliveira; Andrea Name Colado Simão; Edna Maria Vissoci Reiche; Elaine Regina Delicato de Almeida; Helena Kaminami Morimoto; Wildea Lice Carvalho Jennings de Pereira; Daniele Frizon Alfieri; Sueli Donizete Borelli; Domacio Ramon Kaimen-Maciel; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-09-24       Impact factor: 5.590

Review 3.  Psychiatric disorders in multiple sclerosis.

Authors:  Maddalena Sparaco; Luigi Lavorgna; Simona Bonavita
Journal:  J Neurol       Date:  2019-06-13       Impact factor: 4.849

4.  Progressive multiple sclerosis and mood disorders.

Authors:  Lorena Lorefice; G Fenu; G Trincas; M F Moro; J Frau; G C Coghe; E Cocco; M G Marrosu; M G Carta
Journal:  Neurol Sci       Date:  2015-04-22       Impact factor: 3.307

5.  Affective Temperament Profiles in Patients with Multiple Sclerosis: Association with Mood Disorders.

Authors:  Adile Özkan; Kürşat Altinbaş; Emine Rabia Koç; Halil Murat Şen; Handan Işın Özişik Karaman
Journal:  Noro Psikiyatr Ars       Date:  2015-10-22       Impact factor: 1.339

6.  Depression, disability and cognitive impairment in multiple sclerosis: a cross sectional Italian study.

Authors:  Flavia Mattioli; Fabio Bellomi; Chiara Stampatori; Giovanni Parrinello; Ruggero Capra
Journal:  Neurol Sci       Date:  2011-05-19       Impact factor: 3.307

7.  Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.

Authors:  Irene Lambrinoudaki; Elias Patikas; George Kaparos; Eleni Armeni; Demetrios Rizos; Pinelopi Thoda; Andreas Alexandrou; Aristidis Antoniou; George Tsivgoulis; Stergios Gatzonis; Constantinos Panoulis; Nikolaos Triantafyllou
Journal:  Neurol Sci       Date:  2012-12-05       Impact factor: 3.307

8.  Is health anxiety a significant problem for individuals with multiple sclerosis?

Authors:  Melissa D Kehler; Heather D Hadjistavropoulos
Journal:  J Behav Med       Date:  2008-11-18

Review 9.  Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment.

Authors:  Claudio Solaro; Giulia Gamberini; Fabio Giuseppe Masuccio
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

10.  Validity and Reliability of the Greek Version of the Multiple Sclerosis International Quality-of-Life Questionnaire.

Authors:  Nikos Triantafyllou; Aris Triantafillou; Georgios Tsivgoulis
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.